BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37535809)

  • 1. Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.
    De Muynck K; Heyerick L; De Ponti FF; Vanderborght B; Meese T; Van Campenhout S; Baudonck L; Gijbels E; Rodrigues PM; Banales JM; Vesterhuus M; Folseraas T; Scott CL; Vinken M; Van der Linden M; Hoorens A; Van Dorpe J; Lefere S; Geerts A; Van Nieuwerburgh F; Verhelst X; Van Vlierberghe H; Devisscher L
    Hepatology; 2024 Feb; 79(2):269-288. PubMed ID: 37535809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
    Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
    J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
    Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
    Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis.
    De Muynck K; Vanderborght B; De Ponti FF; Gijbels E; Van Welden S; Guilliams M; Scott CL; Beschin A; Vinken M; Lefere S; Geerts A; Verhelst X; Van Vlierberghe H; Devisscher L
    Am J Pathol; 2023 Apr; 193(4):366-379. PubMed ID: 36642171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
    Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
    J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
    Andrews TS; Nakib D; Perciani CT; Ma XZ; Liu L; Winter E; Camat D; Chung SW; Lumanto P; Manuel J; Mangroo S; Hansen B; Arpinder B; Thoeni C; Sayed B; Feld J; Gehring A; Gulamhusein A; Hirschfield GM; Ricciuto A; Bader GD; McGilvray ID; MacParland S
    J Hepatol; 2024 May; 80(5):730-743. PubMed ID: 38199298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
    Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway.
    Jiang B; Yuan G; Wu J; Wu Q; Li L; Jiang P
    Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166320. PubMed ID: 34896545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis.
    Chen YY; Arndtz K; Webb G; Corrigan M; Akiror S; Liaskou E; Woodward P; Adams DH; Weston CJ; Hirschfield GM
    JHEP Rep; 2019 Nov; 1(5):369-376. PubMed ID: 32039388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis.
    Sjöblom N; Boyd S; Kautiainen H; Arola J; Färkkilä M
    Histopathology; 2022 Aug; 81(2):192-204. PubMed ID: 35510514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
    Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
    J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling.
    Meadows V; Kennedy L; Ekser B; Kyritsi K; Kundu D; Zhou T; Chen L; Pham L; Wu N; Demieville J; Hargrove L; Glaser S; Alpini G; Francis H
    Hepatology; 2021 Nov; 74(5):2684-2698. PubMed ID: 34164827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratin 7 expression in hepatic cholestatic diseases.
    Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
    Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
    Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts.
    Özdirik B; Schnabl B
    Cell Mol Gastroenterol Hepatol; 2024; 17(3):423-438. PubMed ID: 38109970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis: diagnosis, prognosis, and management.
    Singh S; Talwalkar JA
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):898-907. PubMed ID: 23454027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
    Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
    Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant peribiliary gland niche exacerbates fibrosis in primary sclerosing cholangitis and a potential therapeutic strategy.
    Wu S; Cao Y; Lu H; Qi X; Sun J; Ye Y; Gong L
    Biomed Pharmacother; 2022 Sep; 153():113512. PubMed ID: 36076599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1.
    Zhuang Y; Ortega-Ribera M; Thevkar Nagesh P; Joshi R; Huang H; Wang Y; Zivny A; Mehta J; Parikh SM; Szabo G
    Hepatology; 2024 Apr; 79(4):752-767. PubMed ID: 37725754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.